The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Liver biopsy, Transient elastography and Cirrhosis. His Internal medicine study often links to related topics such as Surgery. His studies deal with areas such as Fibrosis, Hepatitis C and Receiver operating characteristic as well as Gastroenterology.
His Fibrosis study deals with Biopsy intersecting with Stage and Liver fibrosis. His biological study spans a wide range of topics, including Alcoholic liver disease and Hepatology. He has researched Transient elastography in several fields, including Chronic liver disease, Hepatitis B, Steatosis and Interquartile range.
Victor de Ledinghen mostly deals with Internal medicine, Gastroenterology, Cirrhosis, Hepatitis C and Transient elastography. His Internal medicine research integrates issues from Ribavirin and Hepatitis C virus. The concepts of his Gastroenterology study are interwoven with issues in Biopsy and Fatty liver.
His Cirrhosis research focuses on subjects like Hepatocellular carcinoma, which are linked to Cohort. His Hepatitis C study combines topics from a wide range of disciplines, such as Predictive value of tests, Liver transplantation, NS5A and Viral load. His Transient elastography research is multidisciplinary, incorporating perspectives in Steatosis, Surgery, Chronic liver disease, Nonalcoholic fatty liver disease and Liver stiffness.
Victor de Ledinghen spends much of his time researching Internal medicine, Gastroenterology, Cirrhosis, Chronic liver disease and Cohort. His Internal medicine study frequently draws connections between adjacent fields such as Hepatitis C virus. He interconnects Fibrosis, Hepatocellular carcinoma and Hepatitis B virus in the investigation of issues within Gastroenterology.
His Fibrosis study integrates concerns from other disciplines, such as Biopsy, Obesity and Receiver operating characteristic. His research integrates issues of Cancer, Adverse effect, Retrospective cohort study, First episode and Liver disease in his study of Cirrhosis. His Transient elastography research is included under the broader classification of Liver biopsy.
His primary areas of investigation include Internal medicine, Gastroenterology, Body mass index, Cirrhosis and Cohort. Fatty liver, Nonalcoholic fatty liver disease, Transient elastography, Chronic liver disease and Receiver operating characteristic are among the areas of Internal medicine where Victor de Ledinghen concentrates his study. His Transient elastography research is under the purview of Liver biopsy.
His Gastroenterology study combines topics in areas such as Fibrosis, Proportional hazards model, Hepatitis B virus and Hepatitis C virus. His work deals with themes such as Hepatocellular carcinoma, Interquartile range and Prothrombin time, which intersect with Cirrhosis. His Cohort study incorporates themes from Prospective cohort study and Hepatitis C.
Prospective Comparison of Transient Elastography, Fibrotest, APRI, and Liver Biopsy for the Assessment of Fibrosis in Chronic Hepatitis C
Laurent Castéra;Julien Vergniol;Juliette Foucher;Brigitte Le Bail.
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.
Marianne Ziol;Adriana Handra-Luca;Adrien Kettaneh;Christos Christidis.
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif.
The Lancet Gastroenterology & Hepatology (2017)
Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
Vincent Wai-Sun Wong;Julien Vergniol;Grace Lai-Hung Wong;Juliette Foucher.
Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations.
Laurent Castéra;Juliette Foucher;Pierre-Henri Bernard;Françoise Carvalho.
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa.
Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes
Magali Sasso;Michel Beaugrand;Victor de Ledinghen;Catherine Douvin.
Ultrasound in Medicine and Biology (2010)
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)
Christoph F Dietrich;Jeffrey Bamber;Annalisa Berzigotti;Simona Bota.
Ultraschall in Der Medizin (2017)
Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B
Patrick Marcellin;Marianne Ziol;Pierre Bedossa;Catherine Douvin.
Liver International (2009)
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
Thomas Karlas;David Petroff;Magali Sasso;Jian Gao Fan.
Journal of Hepatology (2017)
If you think any of the details on this page are incorrect, let us know.